- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 12.37M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $169.55M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $186.53M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.83M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.87M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $31.14M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $44.66M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $194.69M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $201.86M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $470.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $496.05M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $478.57M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $495.64M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $790.11M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $815.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.2M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $2.91M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $5.02M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $446.2M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $412.63M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $54.67M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.32M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $3.2M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $63.76M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $138.63M |
| Revenue | Q1 2025 · Mar 31, 2024 | $202.39M |